NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that its board...
2023 Portfolio Receipts expected to be approximately $3,050 million, exceeding the upper end of guidance...
NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.